Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Anlotinib Hydrochloride: Selective VEGFR2 Inhibition in Tumo
2026-07-27
This article examines the preclinical characterization of anlotinib hydrochloride as a highly potent and selective inhibitor of VEGFR2, targeting tumor angiogenesis. The study demonstrates anlotinib's superior specificity and efficacy in inhibiting endothelial cell migration, tube formation, and in vivo tumor vascularization, providing a robust foundation for translational cancer research.
-
Reliable Cell Viability with Cell Counting Kit-8 (CCK-8): La
2026-07-27
This scenario-driven article addresses core challenges in cell viability and cytotoxicity assays faced by biomedical researchers, spotlighting how the Cell Counting Kit-8 (CCK-8, SKU K1018) delivers reproducible, high-sensitivity results. Integrating literature-backed guidance and workflow optimization, the piece provides actionable strategies for adopting CCK-8 in complex experimental contexts.
-
Sulfo-NHS-SS-Biotin Kit: Precision Reversible Biotinylation
2026-07-26
Explore how the Sulfo-NHS-SS-Biotin Kit empowers next-generation, reversible protein and antibody biotinylation for purification and cell surface protein labeling. This article reveals new assay strategies, referencing cutting-edge glycoRNA research, and delivers a practical, protocol-driven perspective that advances beyond existing content.
-
Cannabidiol Modulates Orofacial Pain via Endocannabinoid Pat
2026-07-25
This study demonstrates that cannabidiol (CBD) provides robust relief from both the sensory and emotional components of orofacial inflammatory pain in mouse models. By dissecting peripheral and central endocannabinoid mechanisms, the research reveals how CBD’s multi-dimensional actions are mediated through both CB1 and CB2 receptors, offering a foundation for comprehensive pain management strategies.
-
Skin-Specific DNA Methylation Clocks: A New Platform for Agi
2026-07-24
Boroni et al. (2020) present a highly accurate, skin-specific DNA methylation age predictor that enables precise molecular age estimation in skin tissues and cell cultures. This innovation offers a robust platform for assessing the impact of senotherapeutics and other compounds on skin aging, with broad implications for research on aging, disease, and therapeutic screening.
-
3-Deazaadenosine: Precision Epigenetic Inhibition for Inflam
2026-07-24
Explore how 3-Deazaadenosine, a potent S-adenosylhomocysteine hydrolase inhibitor, enables advanced epigenetic modulation in preclinical inflammation and antiviral research. This article uniquely dissects m6A methylation pathways for translational insights.
-
JC-1 in Advanced Mitochondrial Membrane Potential Assays
2026-07-23
JC-1 empowers researchers to quantify mitochondrial membrane potential with high sensitivity, distinguishing early apoptosis from healthy cell states in real time. This article unpacks practical workflows, advanced applications, and troubleshooting strategies for maximizing JC-1's performance in mitochondrial dysfunction and cellular bioenergetics studies.
-
GPR107 Deficiency Accelerates Diabetic Nephropathy via AT1R
2026-07-23
Xu et al. reveal that GPR107 deficiency disrupts AT1 receptor internalization, intensifying angiotensin II signaling and collagen IV accumulation in diabetic nephropathy. These findings highlight a novel regulatory mechanism in podocyte extracellular matrix turnover, with implications for renal disease research and potential therapeutic targeting.
-
Sulfo-Cy7 NHS Ester: Technical Guide for Protein Labeling
2026-07-22
Cy7 NHS ester (Sulfo-Cy7 NHS Ester) addresses the need for robust, water-soluble near-infrared labeling of proteins and peptides, enabling sensitive fluorescent imaging in live systems. It is best suited for workflows requiring gentle labeling of delicate biomolecules with primary amines and should not be relied on for long-term storage in solution or for targets lacking accessible amino groups.
-
Stabilizing RNA Lipid Nanoparticles for Nebulized Pulmonary
2026-07-22
This study presents a buffer composition-based strategy to enhance the stability of RNA lipid nanoparticles (LNPs) during nebulization, a critical step for efficient pulmonary RNA delivery. By optimizing buffer pH, osmolarity, and excipients, the authors report improved retention of encapsulated RNA and preserved nanoparticle size, expanding the translational potential of inhaled RNA therapeutics.
-
Tetraethylammonium Chloride: Advanced K+ Channel Blockade Wo
2026-07-21
Tetraethylammonium chloride (TEAC) from APExBIO enables precise, dual-site K+ channel inhibition for vascular, neuronal, and metabolic assays. This guide translates cutting-edge reference findings into actionable protocols, workflow optimizations, and troubleshooting steps for robust, reproducible pharmacological and physiological research.
-
ELP-Mediated p21 Peptide Delivery Suppresses Glioblastoma Gr
2026-07-21
This study demonstrates that intracellular delivery of a p21-derived inhibitory peptide via elastin-like polypeptides (ELPs) effectively suppresses proliferation of multiple glioblastoma cell lines through cytostatic mechanisms. The findings highlight the potential of ELP-CPP platforms for overcoming delivery barriers in brain tumor therapeutics and inform future strategies in targeted peptide drug development.
-
HyperPFU™ high-fidelity DNA polymerase: Practical PCR Guidan
2026-07-20
HyperPFU™ high-fidelity DNA polymerase addresses the technical challenges of amplifying long or GC-rich DNA templates that are prone to errors with standard polymerases. It should be selected for workflows requiring blunt-ended, high-accuracy products but is not suitable for applications needing 3'-A overhangs or sticky-end ligation.
-
Sulfo-NHS-SS-Biotin Kit: Precision Reversible Protein Labeli
2026-07-20
The Sulfo-NHS-SS-Biotin Kit enables water-soluble, amine-reactive, and reversible protein biotinylation. Its disulfide-cleavable linker supports advanced cell surface protein and glycoRNA interactome studies. This dossier details its mechanism, benchmarks, and practical workflow integration.
-
Biotin-16-UTP: Precision RNA Labeling for Protein Interactio
2026-07-19
Biotin-16-UTP enables high-specificity, scalable RNA labeling for sensitive detection and purification in molecular biology. This guide translates recent research breakthroughs into practical workflows, troubleshooting insights, and comparative advantages for RNA-protein interaction studies.